COVID-19 took the lives of more than one million Americans and nearly 116,000 Californians, according to the Centers for Disease Control and Prevention.
Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...
An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...
An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...
Pamela Bjorkman of the California Institute of Technology won the prize for ‘offering new hope in the fight against ...
The COVID-19 pandemic transformed over the past five years from a catastrophic threat that has killed over 7 million people ...
This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of ...
An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
There is no disagreement that foreign aid makes a difference; more resources are needed, not less. An estimated US$22 billion ...
In the west of Kenya, near the shores of Lake Victoria, where I come from, a tuberculosis outbreak is no different from one ...
The cuts affect a wide range of programs -- from HIV treatment and malaria prevention in Africa to maternal health care in Nepal.
CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback